To the full analysis
Bruker stock: growth
BRKRBruker reported $3.44B in revenue for fiscal 2025, up 2.1% on the prior year, up 11.6% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
11.5%
per year from 2006 to 2025, per share 9.1%
Earnings (Annual rate)
no data
Free cash flow (Annual rate)
−4%
per year from 2006 to 2025, per share −6%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 11.6% | 7.8% | 11.5% |
| Revenue per share | 11.8% | 8.9% | 9.1% |
| Earnings | no data | no data | no data |
| Earnings per share | no data | no data | no data |
| Free cash flow | −43.2% | −23.2% | −4.0% |
| Free cash flow per share | −43.1% | −22.4% | −6.0% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $435.83M | $18.48M | $30.07M |
| 2007 | $547.58M | $31.53M | $12.13M |
| 2008 | $1.11B | $64.9M | $59.5M |
| 2009 | $1.11B | $81.2M | $133.5M |
| 2010 | $1.3B | $95.4M | $124.2M |
| 2011 | $1.65B | $92.3M | $33.3M |
| 2012 | $1.79B | $77.5M | $60.3M |
| 2013 | $1.84B | $80.1M | $94.7M |
| 2014 | $1.81B | $56.7M | $80.5M |
| 2015 | $1.62B | $101.6M | $195M |
| 2016 | $1.61B | $153.6M | $93.7M |
| 2017 | $1.77B | $78.6M | $110.7M |
| 2018 | $1.9B | $179.7M | $190.5M |
| 2019 | $2.07B | $197.2M | $140.4M |
| 2020 | $1.99B | $157.8M | $235M |
| 2021 | $2.42B | $277.1M | $190.4M |
| 2022 | $2.53B | $296.6M | $145.2M |
| 2023 | $2.96B | $427.2M | $243.2M |
| 2024 | $3.37B | $113.1M | $136M |
| 2025 | $3.44B | −$8.6M | $13.9M |
Revenue by segment
How Bruker Corporation makes its money and how that has shifted. Names are as the company reports them.
- Product81%
- Product and Service, Other19%
Figures as a table
| 2024 | 2025 | Share 2025 | |
|---|---|---|---|
| Product | $2.76B | $2.77B | 80.5% |
| Product and Service, Other | $607.2M | $670.1M | 19.5% |
| Total revenue | $3.37B | $3.44B | 100% |
Revenue by region
Where Bruker Corporation generates its revenue.
- Europe Excluding Germany$950.2M28%
- United States$891.3M26%
- Asia Pacific Excluding China$552.6M16%
- China$475.8M14%
- Germany$297.0M9%
- Other$269.6M8%
“Other” combines smaller regions with revenue the company does not assign to a region. The company split earlier years differently. A history would not be comparable, so only 2025 is shown.
Figures as a table
| 2025 | Share 2025 | |
|---|---|---|
| Europe Excluding Germany | $950.2M | 27.7% |
| United States | $891.3M | 25.9% |
| Asia Pacific Excluding China | $552.6M | 16.1% |
| China | $475.8M | 13.8% |
| Germany | $297M | 8.6% |
| Other | $269.6M | 7.8% |
| Total revenue | $3.44B | 100% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 5 Nov 2026)
- Valuation signal Overvalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.